SNP | CHR:Position (bp)a | Distance from 5′ of SOX9 | Coded allele (AF) | Non-coded allele | Nose Traits | Association results |  | Meta-analysis (Phase 1 + SOX9 replication) | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | beta ± se | P-value |  | beta ± se | P-value | Q | I2 | ||||||
rs9915190 | 7:66,654,223 | 974 kb | A(0.45) | C | Nasal tip protrusion | Phase 1 | −0.015 ± 0.003 | 6.03 × 10−6 |  | − 0.016 ± 0.003 | 1.72 × 10 − 9 | 0.72 | 0.00 |
 | Phase 1 (3 SNPs conditional) | −0.016 ± 0.003 | 2.08 × 10− 6 |  |  |  |  |  | |||||
 | SOX9 replication set | − 0.017 ± 0.004 | 7.04 × 10− 5 |  |  |  |  |  | |||||
Nasal bridge depth | Phase 1 | − 0.198 ± 0.063 | 1.68 × 10−3 |  | − 0.112 ± 0.052 | 3.05 × 10− 2 | 0.02 | 82.56 | |||||
 | Phase 1 (3 SNPs conditional) | −0.204 ± 0.063 | 1.22 × 10− 3 |  |  |  |  |  | |||||
 | SOX9 replication set | 0.066 ± 0.091 | 4.65 × 10−1 |  |  |  |  |  | |||||
Profile nasal area | Phase 1 | − 0.017 ± 0.003 | 3.10 × 10− 7 |  | − 0.016 ± 0.003 | 2.34 × 10 − 9 | 0.61 | 0.00 | |||||
 | Phase 1 (3 SNPs conditional) | − 0.017 ± 0.003 | 1.26 × 10− 7 |  |  |  |  |  | |||||
 | SOX9 replication set | −0.014 ± 0.005 | 1.91 × 10− 3 |  |  |  |  |  | |||||
Nasolabial angle | Phase 1 | 0.007 ± 0.002 | 3.21 × 10− 3 |  | 0.009 ± 0.002 | 2.68 × 10− 5 | 0.34 | 0.00 | |||||
 | Phase 1 (3 SNPs conditional) | 0.008 ± 0.002 | 1.69 × 10− 3 |  |  |  |  |  | |||||
 | SOX9 replication set | 0.011 ± 0.004 | 1.73 × 10− 3 |  |  |  |  |  | |||||
Profile nasal angle | Phase 1 | 0.005 ± 0.001 | 5.79 × 10− 6 |  | 0.004 ± 0.001 | 4.07 × 10− 7 | 0.47 | 0.00 | |||||
 | Phase 1 (3 SNPs conditional) | 0.005 ± 0.001 | 1.02 × 10− 6 |  |  |  |  |  | |||||
 | SOX9 replication set | 0.003 ± 0.001 | 1.83 × 10− 2 |  |  |  |  |  | |||||
rs1859979 | 7:66,940,738 | 688 kb | C(0.46) | T | Nasal tip protrusion | Phase 1 | 0.018 ± 0.003 | 1.56 × 10− 7 |  | 0.017 ± 0.003 | 1.91 × 10 − 10 | 0.68 | 0.00 |
 | Phase 1 (3 SNPs conditional) | 0.017 ± 0.003 | 7.50 × 10− 7 |  |  |  |  |  | |||||
 | SOX9 replication set | 0.016 ± 0.004 | 2.98 × 10− 4 |  |  |  |  |  | |||||
Nasal bridge depth | Phase 1 | 0.331 ± 0.064 | 2.21 × 10− 7 |  | 0.272 ± 0.052 | 1.92 × 10− 7 | 0.11 | 61.76 | |||||
 | Phase 1 (3 SNPs conditional) | 0.323 ± 0.064 | 4.76 × 10− 7 |  |  |  |  |  | |||||
 | SOX9 replication set | 0.152 ± 0.091 | 9.33 × 10− 2 |  |  |  |  |  | |||||
Profile nasal area | Phase 1 | 0.022 ± 0.003 | 8.07 × 10 − 11 |  | 0.018 ± 0.003 | 7.22 × 10 − 12 | 0.09 | 64.77 | |||||
 | Phase 1 (3 SNPs conditional) | 0.020 ± 0.003 | 1.39 × 10 − 9 |  |  |  |  |  | |||||
 | SOX9 replication set | 0.012 ± 0.005 | 6.59 × 10− 3 |  |  |  |  |  | |||||
Nasolabial angle | Phase 1 | −0.011 ± 0.002 | 9.86 × 10− 6 |  | − 0.013 ± 0.002 | 1.13 × 10 − 10 | 0.11 | 60.21 | |||||
 | Phase 1 (3 SNPs conditional) | − 0.011 ± 0.002 | 2.10 × 10− 5 |  |  |  |  |  | |||||
 | SOX9 replication set | −0.018 ± 0.004 | 8.09 × 10− 7 |  |  |  |  |  | |||||
Profile nasal angle | Phase 1 | − 0.006 ± 0.001 | 2.37 × 10 − 9 |  | − 0.007 ± 0.001 | 9.58 × 10 − 15 | 0.63 | 0.00 | |||||
 | Phase 1 (3 SNPs conditional) | − 0.006 ± 0.001 | 2.53 × 10 − 9 |  |  |  |  |  | |||||
 | SOX9 replication set | − 0.007 ± 0.001 | 8.17 × 10− 7 |  |  |  |  |  | |||||
rs9910003 | 7:67,390,279 | 238 kb | A(0.28) | G | Nasal tip protrusion | Phase 1 | 0.015 ± 0.004 | 4.05 × 10− 5 |  |  |  |  |  |
 | Phase 1 (3 SNPs conditional) | 0.007 ± 0.004 | 9.07 × 10− 2 |  |  |  |  |  | |||||
 | SOX9 replication set |  |  |  |  |  |  |  | |||||
Nasal bridge depth | Phase 1 | 0.038 ± 0.071 | 5.90 × 10− 1 |  |  |  |  |  | |||||
 | Phase 1 (3 SNPs conditional) | − 0.077 ± 0.079 | 3.33 × 10− 1 |  |  |  |  |  | |||||
 | SOX9 replication set |  |  |  |  |  |  |  | |||||
Profile nasal area | Phase 1 | 0.007 ± 0.004 | 7.71 × 10− 2 |  |  |  |  |  | |||||
 | Phase 1 (3 SNPs conditional) | 0.001 ± 0.004 | 8.50 × 10− 1 |  |  |  |  |  | |||||
 | SOX9 replication set |  |  |  |  |  |  |  | |||||
Nasolabial angle | Phase 1 | −0.011 ± 0.003 | 1.12 × 10− 4 |  |  |  |  |  | |||||
 | Phase 1 (3 SNPs conditional) | −0.004 ± 0.003 | 1.99 × 10− 1 |  |  |  |  |  | |||||
 | SOX9 replication set |  |  |  |  |  |  |  | |||||
Profile nasal angle | Phase 1 | −0.004 ± 0.001 | 3.87 × 10− 4 |  |  |  |  |  | |||||
 | Phase 1 (3 SNPs conditional) | 0.000 ± 0.001 | 8.06 × 10− 1 |  |  |  |  |  | |||||
 | SOX9 replication set |  |  |  |  |  |  |  | |||||
rs2193054 | 17:67,537,404 | 91 kb | C(0.47) | G | Nasal tip protrusion | Phase 1 | 0.019 ± 0.003 | 1.93 × 10 − 8 |  | 0.017 ± 0.003 | 1.85 × 10 − 10 | 0.35 | 0.00 |
 | Phase 1 (3 SNPs conditional) | 0.015 ± 0.004 | 3.26 × 10− 5 |  |  |  |  |  | |||||
 | SOX9 replication set | 0.013 ± 0.004 | 1.74 × 10− 3 |  |  |  |  |  | |||||
Nasal bridge depth | Phase 1 | 0.165 ± 0.062 | 8.02 × 10−3 |  | 0.130 ± 0.051 | 1.10 × 10− 2 | 0.33 | 0.00 | |||||
 | Phase 1 (3 SNPs conditional) | 0.211 ± 0.070 | 2.50 × 10− 3 |  |  |  |  |  | |||||
 | SOX9 replication set | 0.057 ± 0.091 | 5.30 × 10− 1 |  |  |  |  |  | |||||
Profile nasal area | Phase 1 | 0.010 ± 0.003 | 1.33 × 10− 3 |  | 0.010 ± 0.003 | 8.14 × 10− 5 | 0.98 | 0.00 | |||||
 | Phase 1 (3 SNPs conditional) | 0.011 ± 0.004 | 3.62 × 10− 3 |  |  |  |  |  | |||||
 | SOX9 replication set | 0.010 ± 0.005 | 2.25 × 10−2 |  |  |  |  |  | |||||
Nasolabial angle | Phase 1 | −0.014 ± 0.002 | 1.56 × 10 − 8 |  | − 0.013 ± 0.002 | 2.25 × 10 − 10 | 0.49 | 0.00 | |||||
 | Phase 1 (3 SNPs conditional) | −0.012 ± 0.003 | 7.34 × 10− 6 |  |  |  |  |  | |||||
 | SOX9 replication set | − 0.011 ± 0.004 | 3.35 × 10− 3 |  |  |  |  |  | |||||
Profile nasal angle | Phase 1 | − 0.007 ± 0.001 | 1.43 × 10 − 11 |  | − 0.006 ± 0.001 | 9.01 × 10 − 14 | 0.24 | 27.90 | |||||
 | Phase 1 (3 SNPs conditional) | −0.007 ± 0.001 | 1.50 × 10 − 9 |  |  |  |  |  | |||||
 | SOX9 replication set | − 0.005 ± 0.001 | 8.53 × 10− 4 |  |  |  |  |  |